Relation of the multilocus genetic composite reflecting high dopamine signaling capacity to future increases in BMI

Appetite

Volumn 87, Issue , 2015, Pages 38-45

  Yokum, Sonja ^a   Marti, C Nathan ^a   Smolen, Andrew ^b   Stice, Eric ^a  

^a OREGON RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Body mass index; Dopamine; Multilocus genetic composite; Obesity; Weight gain

Indexed keywords

CATECHOL METHYLTRANSFERASE; DNA; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BODY MASS; CLINICAL ARTICLE; DNA EXTRACTION; EPITHELIUM CELL; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MALE; REWARD; SALIVA; SIGNAL TRANSDUCTION; WEIGHT GAIN; WEIGHT REDUCTION; CALORIC INTAKE; EATING; GENETICS; HYPERPHAGIA; METABOLISM; OBESITY; PROSPECTIVE STUDY; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ALLELES; BODY MASS INDEX; DOPAMINE; EATING; ENERGY INTAKE; FEMALE; GENOTYPE; HUMANS; HYPERPHAGIA; MALE; OBESITY; PROSPECTIVE STUDIES; REWARD; RISK FACTORS; SALIVA; SIGNAL TRANSDUCTION; WEIGHT GAIN; YOUNG ADULT;

EID: 84922295347     PISSN: 01956663     EISSN: 10958304     Source Type: Journal    
DOI: 10.1016/j.appet.2014.12.202     Document Type: Article

References (61)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Association, Washington, DC, text revision. 4th ed.
2. Asghari V., Sanyal S., Buchwaldt S., Paterson A., Jovanovic V., Van Tol H.H. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. Journal of Neurochemistry 1995, 65:1157-1165.
3. Avena N.M., Rada P., Hoebel B.G. Sugar and fat bingeing have notable differences in addictive-like behavior. The Journal of Nutrition 2009, 139:623-628.
4. Berkey C.S., Colditz G.A. Adiposity in adolescents. Change in actual BMI works better than change in BMI z score for longitudinal studies. Annals of Epidemiology 2007, 17:44-50.
5. Berridge K.C., Ho C.Y., Richard J.M., DiFeliceantonio A.G. The tempted brain eats. Pleasure and desire circuits in obesity and eating disorders. Brain Research 2010, 1350:43-64.
6. Beyerlein A., von Kries R., Ness A.R., Ong K.K. Genetic markers of obesity risk. Stronger associations with body composition in overweight compared to normal-weight children. PLoS ONE 2011, 6:e19057.
7. Blendy J.A., Strasser A., Walters C.L., Perkins K.A., Patterson F., Berkowitz R., et al. Reduced nicotine reward in obesity. Cross-comparison in human and mouse. Psychopharmacology 2005, 180:306-315.
8. Blüml V., Kapusta N., Vyssoki B., Kogoj D., Walter H., Lesch O.M. Relationship between substance use and body mass index in young males. The American Journal on Addictions 2012, 21:72-77.
9. Burnham K.P., Anderson D. Model selection and multi-model inference. A practical information-theoretic approach 2002, Springer, New York, NY.
10. Cameron J.D., Riou M.E., Tesson F., Goldfield G.S., Rabasa-Lhoret R., Brochu M., et al. The TaqIA RFLP is associated with attenuated intervention-induced body weight loss and increased carbohydrate intake in post-menopausal obese women. Appetite 2013, 60:111-116.
11. Centers for Disease Control (CDC website) Last accessed 7.30.12. http://www.cdc.gov/obesity/data/adult.html.
12. Davis C., Loxton N.J. Addictive behaviors and addiction-prone personality traits. Associations with a dopamine multilocus genetic profile. Addictive Behaviors 2013, 38:2306-2312.
13. Davis C., Loxton N.J., Levitan R.D., Kaplan A.S., Carter J.C., Kennedy J.L. 'Food addiction' and its association with a dopaminergic multilocus genetic profile. Physiology and Behavior 2013, 118:63-69.
14. Demos K.E., Heatherton T.F., Kelley W.M. Individual differences in nucleus accumbens activity to food and sexual images predict weight gain and sexual behavior. Journal of Neuroscience 2012, 32:5549-5552.
15. Dietz W.H., Robinson T.N. Use of the body mass index (BMI) as a measure of overweight in children and adolescents. The Journal of Pediatrics 1998, 132:191-193.
16. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:6917-6922.
17. Elks C.E., Loos R.J., Sharp S.J., Langenberg C., Ring S.M., Timpson N.J., et al. Genetic markers of adult obesity risk are associated with greater early infancy weight gain and growth. PLoS Medicine 2010, 7:e1000284.
18. Ferreira J.G., Tellez L.A., Ren X., Yeckel C.W., de Araujo I.E. Regulation of fat intake in the absence of flavor signaling. The Journal of Physiology 2012, 590:953-972.
19. Fuemmeler B.F., Agurs-Collins T.D., McClernon F.J., Kollins S.H., Kail M.E., Bergen A.W., et al. Genes implicated in serotonergic and dopaminergic functioning predict BMI categories. Obesity 2008, 16:348-355.
20. Geha P.Y., Aschenbrenner K., Felsted J., O'Malley S.S., Small D.M. Altered hypothalamic response to food in smokers. The American Journal of Clinical Nutrition 2013, 97:15-22.
21. Hardman C.A., Rogers P.J., Timpson N.J., Munafo M.R. Lack of association between DRD2 and OPRM1 genotypes and adiposity. International Journal of Obesity 2014, 38:730-736.
22. Heal D.J., Smith S.L., Gosden J., Nutt D.J. Amphetamine, past and present. A pharmacological and clinical perspective. Journal of Psychopharmacology (Oxford, England) 2013, 27:479-496.
23. Heinz A., Goldman D., Jones D.W., Palmour R., Hommer D., Gorey J.G., et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000, 22:133-139.
24. Jonsson E.G., Nothen M.M., Grunhage F., Farde L., Nakashima Y., Propping P., et al. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers. Molecular Psychiatry 1999, 4:290-296.
25. Kessler R.M., Zald D.H., Ansari M.S., Li R., Cowan R.L. Changes in dopamine release and dopamine D2/3 receptor levels with the development of mild obesity. Synapse (New York, N.Y.) 2014, 68:317-320.
26. Kutner M.H., Nachtsheim C.J., Neter J., Li W. Applied linear statistical models 2005, McGraw-Hill, New York, NY.
27. Loos R.J., Yeo G.S. The bigger picture of FTO. The first GWAS-identified obesity gene. Nature Reviews. Endocrinology 2014, 10:51-61.
28. McCarthy H.D., Cole T.J., Fry T., Jebb S.A., Prentice A.M. Body fat reference curves for children. International Journal of Obesity 2006, 30:598-602.
29. McMurray R.G., Harrell J.S., Creighton D., Wang Z., Bangdiwala S.I. Influence of physical activity on change in weight status as children become adolescents. International Journal of Pediatric Obesity 2008, 3:69-77.
30. Mei H., Chen W., Jiang F., He J., Srinivasan S., Smith E.N., et al. Longitudinal replication studies of GWAS risk SNPs influencing body mass index over the course of childhood and adulthood. PLoS ONE 2012, 7:e31470.
31. Mei Z., Grummer-Strawn L.M., Pietrobelli A., Goulding A., Goran M.I., Dietz W.H. Validity of body mass index compared with other body-composition screening indexes for the assessment of body fatness in children and adolescents. The American Journal of Clinical Nutrition 2002, 75:978-985.
32. Muller D.J., Zai C.C., Sicard M., Remington E., Souza R.P., Tiwari A.K., et al. Systematic analysis of dopamine receptor genes (DRD1-DRD5) in antipsychotic-induced weight gain. The Pharmacogenomics Journal 2012, 12:156-164.
33. Nikolova Y.S., Ferrell R.E., Manuck S.B., Hariri A.R. Multilocus genetic profile for dopamine signaling predicts ventral striatum reactivity. Neuropsychopharmacology 2011, 36:1940-1947.
34. Noble E.P., Blum K., Ritchie T., Montgomery A., Sheridan P.J. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Archives of General Psychiatry 1991, 48:648-654.
35. Ogden C.L., Carroll M.D., Kit B.K., Flegal K.M. Prevalence of obesity in the United States, 2009-2010. JAMA: The Journal of the American Medical Association 2012, 82:1-8.
36. Pinheiro J., Bates D., DebRoy S., Sarkar D. nlme. Linear and Nonlinear Mixed Effects Models (version 3.1-113) R Core Team, Last accessed 14.02. http://cran.r-project.org/web/packages/nlme/nlme.pdf.
37. Prentice A.M., Jebb S.A. Beyond body mass index. Obesity Reviews 2001, 2:141-147.
38. Roth C.L., Hinney A., Schur E.A., Elfers C.T., Reinehr T. Association analyses for dopamine receptor gene polymorphisms and weight status in a longitudinal analysis in obese children before and after lifestyle intervention. BMC Pediatrics 2013, 13:197.
39. Sallis J.F. Epidemiology of physical activity and fitness in children and adolescents. Critical Reviews in Food Science and Nutrition 1993, 33:403-408.
40. Schwenk R.W., Vogel H., Schurmann A. Genetic and epigenetic control of metabolic health. Molecular Metabolism 2013, 2:337-347.
41. Seeger G., Schloss P., Schmidt M.H. Marker gene polymorphisms in hyperkinetic disorder-predictors of clinical response to treatment with methylphenidate?. Neuroscience Letters 2001, 313:45-48.
42. Simon G.E., Von Korff M., Saunders K., Miglioretti D.L., Crane P.K., van Belle G., et al. Association between obesity and psychiatric disorders in the US adult population. Archives of General Psychiatry 2006, 63:824-830.
43. Singer J.W., Willet J. Applied longitudinal data analysis. Modeling change and event occurrence 2003, Oxford University Press, New York, NY.
44. Small D.M., Jones-Gotman M., Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage 2003, 19:1709-1715.
45. Small D.M., Zatorre R.J., Dagher A., Evans A.C., Jones-Gotman M. Changes in brain activity related to eating chocolate. From pleasure to aversion. Brain: A Journal of Neurology 2001, 124:1720-1733.
46. Speliotes E.K., Willer C.J., Berndt S.I., Monda K.L., Thorleifsson G., Jackson A.U., et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nature Genetics 2010, 42:937-948.
47. Steinberger J., Jacobs D.R., Raatz S., Moran A., Hong C.P., Sinaiko A.R. Comparison of body fatness measurements by BMI and skinfolds vs dual energy X-ray absorptiometry and their relation to cardiovascular risk factors in adolescents. International Journal of Obesity 2005, 29:1346-1352.
48. Stice E., Burger K.S., Yokum S. Relative ability of fat and sugar tastes to activate reward, gustatory, and somatosensory regions. The American Journal of Clinical Nutrition 2013, 98:1377-1384.
49. Stice E., Shaw H., Marti C.N. A meta-analytic review of obesity prevention programs for children and adolescents. The skinny on interventions that work. Psychological Bulletin 2006, 132:667-691.
50. Stice E., Spoor S., Bohon C., Small D.M. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008, 322:449-452.
51. Stice E., Spoor S., Bohon C., Veldhuizen M.G., Small D.M. Relation of reward from food intake and anticipated food intake to obesity. A functional magnetic resonance imaging study. Journal of Abnormal Psychology 2008, 117:924-935.
52. Stice E., Yokum S., Bohon C., Marti N., Smolen A. Reward circuitry responsivity to food predicts future increases in body mass. Moderating effects of DRD2 and DRD4. Neuroimage 2010, 50:1618-1625.
53. Stice E., Yokum S., Burger K., Epstein L., Smolen A. Multilocus genetic composite reflecting dopamine signaling capacity predicts reward circuitry responsivity. Journal of Neuroscience 2012, 32:10093-10100.
54. Stice E., Yokum S., Burger K.S., Epstein L.H., Small D.M. Youth at risk for obesity show greater activation of striatal and somatosensory regions to food. Journal of Neuroscience 2011, 31:4360-4366.
55. Turk M.W., Yang K., Hravnak M., Sereika S.M., Ewing L.J., Burke L.E. Randomized clinical trials of weight loss maintenance. A review. The Journal of Cardiovascular Nursing 2009, 24:58-80.
56. Warren M., Frost-Pineda K., Gold M. Body mass index and marijuana use. Journal of Addictive Diseases 2005, 24:95-100.
57. Warrington N.M., Howe L.D., Wu Y.Y., Timpson N.J., Tilling K., Pennell C.E., et al. Association of a body mass index genetic risk score with growth throughout childhood and adolescence. PLoS ONE 2013, 8:e79547.
58. White M.A., Whisenhunt B.L., Williamson D.A., Greenway F.L., Netemeyer R.G. Development and validation of the food-craving inventory. Obesity Research 2002, 10:107-114.
59. Winkler J.K., Woehning A., Schultz J.H., Brune M., Beaton N., Challa T.D., et al. TaqIA polymorphism in dopamine D2 receptor gene complicates weight maintenance in younger obese patients. Nutrition (Burbank, Los Angeles County, Calif.) 2012, 28:996-1001.
60. Wirshing D.A., Wirshing W.C., Kysar L., Berisford M.A., Goldstein D., Pashdag J., et al. Novel antipsychotics. Comparison of weight gain liabilities. The Journal of Clinical Psychiatry 1999, 60:358-363.
61. Yokum S., Gearhardt A.N., Harris J.L., Brownell K.D., Stice E. Individual differences in striatum activity to food commercials predict weight gain in adolescents. Obesity 2014, 22:2544-2551.